CN Stock MarketDetailed Quotes

Sichuan Biokin Pharmaceutical (688506)

Watchlist
  • 258.75
  • -5.85-2.21%
Market Closed May 14 15:00 CST
106.83BMarket Cap-82.38P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Sichuan Biokin Pharmaceutical (688506) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
知识产权收入2.12B84.30%
Chemical preparation284.08M11.27%
中成药制剂96M3.81%
Total special adjustments14.07M0.56%
Other business1.62M0.06%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry2.52B99.94%
Other business1.62M0.06%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Overseas2.12B84.30%
Territory380.08M15.08%
Total special adjustments14.07M0.56%
Other business1.62M0.06%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Petroleum
No. Symbol 20D % Chg
Sample Name
Sample Code
 +3.66%
Sample Name
Sample Code
 +3.21%
Sample Name
Sample Code
 +1.57%
4
SINOPEC CORP
00386
+0.66%
5
CNOOC
00883
+0.53%
View More
No. Symbol 20D % Chg
Sample Name
Sample Code
 +47.30%
Sample Name
Sample Code
 +42.24%
Sample Name
Sample Code
 +30.17%
4
Loongson Technology Corporation
688047
+19.58%
5
Digital China Group
000034
+16.92%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Axios, on Sunday local time, Trump rejected Iran's latest ceasefire proposal, prompting a sharp response from Iran: no one woul Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -